Interestingly, we found increased levels of proinflammatory intermediate CD14++CD16+ monocytes in CRS-2 patients as compared to CKD patients, albeit no significant differences were detected between other robust markers of inflammation, such as CRP or ESR between the two cohorts. Here, CD14 is linked to chronic kidney disease.